Literature DB >> 18985284

Chronic infections and atherosclerosis.

Kiyoshi Ayada1, Kenji Yokota, Kazuko Kobayashi, Yehuda Shoenfeld, Eiji Matsuura, Keiji Oguma.   

Abstract

The immune response against heat shock protein 60 (HSP60) derived from pathogens causing chronic infections is thought to be an important pro-atherogenic mechanism because high serum levels of antibodies against HSP60 have been associated with atherosclerotic diseases, such as coronary artery diseases, or cerebro-vascular events. Furthermore, the presence of HSP60-specific T lymphocytes in circulation may increase the risk of atherosclerosis. Our recent in vitro and in vivo studies have also shown an association of Helicobacter pylori-HSP60 (Hp-HSP60) specific Th1 immune responses elicited by H. pylori infection with the progression of atherosclerosis in a hyperlipidemic mouse model. These Th1 dominant immune responses may cross-react with endogenous HSP60 expressed on stressed cells of the vascular endothelium, likely due to molecular mimicry. However, the exact mechanisms by which endothelial cells display their HSP60 molecule or present HSP60 antigenic epitopes on the surface are still unclear.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18985284     DOI: 10.1007/s12016-008-8097-7

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  44 in total

1.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

2.  Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.

Authors:  Douglas O Sobel; Karen Creswell
Journal:  Autoimmunity       Date:  2006-06       Impact factor: 2.815

Review 3.  Role of antiheat shock protein 60 autoantibodies in atherosclerosis.

Authors:  K Mandal; G Foteinos; M Jahangiri; Q Xu
Journal:  Lupus       Date:  2005       Impact factor: 2.911

4.  Heat shock protein 60 autoimmunity and early lipid lesions in cholesterol-fed C57BL/6JBom mice during Chlamydia pneumoniae infection.

Authors:  L Erkkilä; K Laitinen; K Haasio; T Tiirola; M Jauhiainen; H A Lehr; K Aalto-Setälä; P Saikku; M Leinonen
Journal:  Atherosclerosis       Date:  2004-12       Impact factor: 5.162

5.  Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques.

Authors:  Marisa Benagiano; Mario M D'Elios; Amedeo Amedei; Annalisa Azzurri; Ruurd van der Zee; Alessandra Ciervo; Gianni Rombolà; Sergio Romagnani; Antonio Cassone; Gianfranco Del Prete
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

6.  Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis.

Authors:  Jianhui Zhu; Richard J Katz; Arshed A Quyyumi; Daniel A Canos; David Rott; Gyorgy Csako; Alexandra Zalles-Ganley; Jibike Ogunmakinwa; Alan G Wasserman; Stephen E Epstein
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

7.  Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions.

Authors:  R Kleindienst; Q Xu; J Willeit; F R Waldenberger; S Weimann; G Wick
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

8.  T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions.

Authors:  Marisa Benagiano; Annalisa Azzurri; Alessandra Ciervo; Amedeo Amedei; Carlo Tamburini; Mauro Ferrari; John L Telford; Cosima T Baldari; Sergio Romagnani; Antonio Cassone; Mario M D'Elios; Gianfranco Del Prete
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

9.  Levels of intra- and extracellular heat shock protein 60 in Kawasaki disease patients treated with intravenous immunoglobulin.

Authors:  Xu Yin Ji; Mi-Ran Kang; Jong-Sung Choi; Hak-Soo Jeon; Heon-Seok Han; Ji-Yoon Kim; Bo-Ra Son; Young-Min Lee; Youn-Soo Hahn
Journal:  Clin Immunol       Date:  2007-07-02       Impact factor: 3.969

10.  Antibodies against heat shock protein 60 derived from Helicobacter pylori: diagnostic implications in cardiovascular disease.

Authors:  Tomoyuki Okada; Kiyoshi Ayada; Shinichi Usui; Kenji Yokota; Jinhua Cui; Yoshiro Kawahara; Tomoki Inaba; Satoshi Hirohata; Motowo Mizuno; Daisuke Yamamoto; Shozo Kusachi; Eiji Matsuura; Keiji Oguma
Journal:  J Autoimmun       Date:  2007-07-02       Impact factor: 7.094

View more
  15 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Helicobacter pylori: Does it add to risk of coronary artery disease.

Authors:  Vishal Sharma; Amitesh Aggarwal
Journal:  World J Cardiol       Date:  2015-01-26

3.  Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.

Authors:  Sergio A Machado; Janice M Bahr; D Buck Hales; Andrea G Braundmeier; Bradley J Quade; Romana A Nowak
Journal:  Biol Reprod       Date:  2012-10-11       Impact factor: 4.285

4.  Comparison of epitope specificity of anti-heat shock protein 60/65 IgG type antibodies in the sera of healthy subjects, patients with coronary heart disease and inflammatory bowel disease.

Authors:  George Füst; Katalin Uray; László Bene; Ferenc Hudecz; István Karádi; Zoltán Prohászka
Journal:  Cell Stress Chaperones       Date:  2011-10-29       Impact factor: 3.667

5.  Multiparametric assessment of vascular function and atherosclerosis in patients with autoimmune gastritis: a comparative study.

Authors:  Mustafa Yakut; Yusuf Ustün; Sim Kutlay; Aydan Ongun; Gökhan Kabaçam; Recai Boynueğri; Irfan Soykan
Journal:  Dig Dis Sci       Date:  2011-06-17       Impact factor: 3.199

6.  Helicobacter pylori infection contributes to high risk of ischemic stroke: evidence from a meta-analysis.

Authors:  Zhong Wei Wang; Yan Li; Li Yong Huang; Qing Kai Guan; Da Wei Xu; Wen Ke Zhou; Xin Zhong Zhang
Journal:  J Neurol       Date:  2012-06-12       Impact factor: 4.849

7.  Helicobacter pylori vs coronary heart disease - searching for connections.

Authors:  Magdalena Chmiela; Adrian Gajewski; Karolina Rudnicka
Journal:  World J Cardiol       Date:  2015-04-26

8.  The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects.

Authors:  Halide S Akbas; Sebahat Basyigit; Inci Suleymanlar; Didem Kemaloglu; Serkan Koc; Fatih Davran; Ibrahim Demir; Gultekin Suleymanlar
Journal:  Lipids Health Dis       Date:  2010-08-30       Impact factor: 3.876

9.  Comprehensive insight into immune regulatory mechanisms and vascular wall determinants of atherogenesis - emerging perspectives of immunomodulation.

Authors:  Maciej Chalubinski; Katarzyna Wojdan; Roksana Dorantowicz; Paulina Jackowska; Paulina Gorzelak; Marlena Broncel
Journal:  Arch Med Sci       Date:  2013-02-21       Impact factor: 3.318

10.  Low levels of CD36 in peripheral blood monocytes in subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study in a Mexican population.

Authors:  Eduardo Gómez-Bañuelos; Beatriz Teresita Martín-Márquez; Erika Aurora Martínez-García; Mauricio Figueroa-Sanchez; Lourdes Nuñez-Atahualpa; Alberto Daniel Rocha-Muñoz; Pedro Ernesto Sánchez-Hernández; Rosa Elena Navarro-Hernandez; Perla Monserrat Madrigal-Ruiz; Adan Alberto Saldaña-Millan; Sergio Duran-Barragan; Laura Gonzalez-Lopez; Jorge Ivan Gamez-Nava; Mónica Vázquez-Del Mercado
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.